CEACAM5 and neoplasm: To identify potential mechanism(s) of action that predict response or resistance to αTIGIT + bintrafusp alfa combination therapy, we interrogated the transcriptomic landscape within the tumor of MC38-CEA tumor-bearing mice at day 24 post-tumor inoculation.